{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["74(9)"],"submitter":["London NR"],"funding":["Flight Attendant Medical Research Institute","NIAID NIH HHS","NIEHS NIH HHS","NHLBI NIH HHS","Foundation for the National Institutes of Health","American Rhinologic Society"],"journal":["Allergy"],"pagination":["1780-1783"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6848889"],"repository":["biostudies-literature"],"pubmed_title":["Nrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation."],"pmcid":["PMC6848889"],"funding_grant_id":["R01 AI143731","Clinical Investigator Award","R01 HL124099","ES020859","K23 ES020859","R01 HL151107","L30 ES022003"],"pubmed_authors":["Dobzanski A","Mendiola M","Han AH","Chen M","London NR","Sidhaye V","Biswal S","Tharakan A","Zaykaner M","Ramanathan M","Sussan TE","Lane AP"],"additional_accession":[]},"is_claimable":false,"name":"Nrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation.","description":null,"dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Sep","modification":"2025-04-26T18:55:05.114Z","creation":"2025-04-06T15:56:31.459Z"},"accession":"S-EPMC6848889","cross_references":{"pubmed":["30843229"],"doi":["10.1111/all.13766"]}}